Literature DB >> 11317692

Dual effect of chronic nicotine administration: augmentation of jejunitis and amelioration of colitis induced by iodoacetamide in rats.

R Eliakim1, F Karmeli, P Cohen, S N Heyman, D Rachmilewitz.   

Abstract

Smoking has a dichotomous effect on inflammatory bowel disease, ameliorating disease activity in ulcerative colitis but having a deleterious effect on Crohn's disease. This effect is thought to be due to nicotine. We investigated the effect of chronic nicotine administration on the small and large bowel in iodoacetamide-induced jejunitis and colitis. Jejunitis was induced in Sprague-Dawley rats by intrajejunal administration of 0.1 ml 2% iodoacetamide and colitis by intrarectal administration of 0.1 ml 3% iodoacetamide. Nicotine was dissolved in drinking water (12.5 or 250 micrograms/ml), rats drinking ad libitum. Nicotine administration started 10 days prior to damage induction and throughout the experiment and had no effect on weight gain or daily food intake of rats. Rats were killed 5 days after iodoacetamide-induced colitis and 7 days after induction of jejunitis. The jejunum and colon were resected, rinsed, weighed, damage assessed macroscopically and microscopically and tissue processed for myeloperoxidase and nitric oxide synthase (NOS) activities and prostaglandin E2 (PGE2) generation. Effects of nicotine on gut microcirculation were also assessed. Nicotine by itself caused no damage to the colon. Nicotine had a dichotomous effect on jejunitis and colitis. At a dose of 12.5 micrograms/ml nicotine improved the macroscopic damage of colitis from 252 +/- 66 to 70 +/- 31 mm2, and segmental weight also declined significantly in the colon (from 1.7 +/- 0.2 to 1.2 +/- 0.1 g/10 cm). In contrast, the same dose of nicotine had a deleterious effect on iodoacetamide-induced jejunitis, increasing the macroscopic damage from 368 +/- 38 to 460 +/- 97 mm2 in rats treated with injury escalating to 970 +/- 147 in rats treated with 250 micrograms/ml nicotine. Nicotine treatment also significantly increased jejunal segmental weight. By itself nicotine did not change NOS activity or PGE2 generation compared to control rats, but it enhanced microcirculation in the colon, whereas in the jejunum nicotine decreased PGE2 generation and increased NOS activity but not jejunal microcirculation. Nicotine has opposite effects on iodoacetamide-induced colitis and jejunitis, which may be partly explained by decreased PGE2 generation and increased NOS activity in the jejunum and an increase in the colonic microcirculation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11317692     DOI: 10.1007/s003840000262

Source DB:  PubMed          Journal:  Int J Colorectal Dis        ISSN: 0179-1958            Impact factor:   2.571


  15 in total

Review 1.  Effect of smoking on inflammatory bowel disease: Is it disease or organ specific?

Authors:  A Karban; R Eliakim
Journal:  World J Gastroenterol       Date:  2007-04-21       Impact factor: 5.742

Review 2.  The impact of smoking in Crohn's disease: no smoke without fire.

Authors:  Marian C Aldhous; J Satsangi
Journal:  Frontline Gastroenterol       Date:  2010-09-23

3.  Ulcerative colitis and Crohn's disease: is Mycobacterium avium subspecies paratuberculosis the common villain?

Authors:  Ellen S Pierce
Journal:  Gut Pathog       Date:  2010-12-17       Impact factor: 4.181

4.  Cytokine-induced alterations of α7 nicotinic receptor in colonic CD4 T cells mediate dichotomous response to nicotine in murine models of Th1/Th17- versus Th2-mediated colitis.

Authors:  Valentin Galitovskiy; Jing Qian; Alexander I Chernyavsky; Steve Marchenko; Vivian Gindi; Robert A Edwards; Sergei A Grando
Journal:  J Immunol       Date:  2011-07-22       Impact factor: 5.422

Review 5.  Key role of mast cells and their major secretory products in inflammatory bowel disease.

Authors:  Shao-Heng He
Journal:  World J Gastroenterol       Date:  2004-02-01       Impact factor: 5.742

6.  Novel insights on the effect of nicotine in a murine colitis model.

Authors:  Shakir D AlSharari; Hamid I Akbarali; Rehab A Abdullah; Omer Shahab; Wimolnut Auttachoat; Gabriela A Ferreira; Kimber L White; Aron H Lichtman; Guy A Cabral; M Imad Damaj
Journal:  J Pharmacol Exp Ther       Date:  2012-10-31       Impact factor: 4.030

7.  Current smoking improves ulcerative colitis patients' disease behaviour in the northwest of China.

Authors:  Huihong Zhai; Wenyu Huang; Aiqin Liu; Qianqian Li; Qian Hao; Ling Ma; Feng Yang; Shutian Zhang
Journal:  Prz Gastroenterol       Date:  2017-12-14

8.  Dysregulation of human beta-defensin-2 protein in inflammatory bowel disease.

Authors:  Marian C Aldhous; Colin L Noble; Jack Satsangi
Journal:  PLoS One       Date:  2009-07-20       Impact factor: 3.240

9.  Anti-inflammatory effects of the nicotinergic peptides SLURP-1 and SLURP-2 on human intestinal epithelial cells and immunocytes.

Authors:  Alex I Chernyavsky; Valentin Galitovskiy; Igor B Shchepotin; Sergei A Grando
Journal:  Biomed Res Int       Date:  2014-05-04       Impact factor: 3.411

10.  Nicotine Inhibits Clostridium difficile Toxin A-Induced Colitis but Not Ileitis in Rats.

Authors:  Steven R Vigna
Journal:  Int J Inflam       Date:  2016-01-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.